hotspot -WSS

hotspot

author：comprehensive 2025-10-01 04:32:41 - browse：63634

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Pregnancy ages women, but effects reverse after delivery

WSS

Cancer, immunology, HIV research ensnared in fetal tissue politics

Sanofi CEO defends move to abandon profit guidance, boost research

UCSF medical school apologizes for unethical prisoner experiments

Testing GLP

Pfizer, Moderna say biotech, pharma drug development is a sprint

Sanofi CEO defends move to abandon profit guidance, boost research

explore

hotspot

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Steward Health Care expansion into Malta flopped

George Santos makes 1st court appearance after pleading not guilty to 13 counts

White House calls on federal agencies to crack down on AI abuses

How one medical school became remarkably diverse

Sanofi CEO defends move to abandon profit guidance, boost research

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

More doctors should go into startup world

Anesthesiologist group: stop taking Ozempic before surgery

MoonLake credibility takes another hit with mid

hotspot

Removing probiotics from the NICU could threaten preemies' health

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

This gene therapy has record $4.25 million price. It's saved children.

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Medicare Advantage insurers pressure Biden for bigger payments

The new shift in health care is toward less care

hotspot

entertainment

explore

Wikipedia